Patents by Inventor Frank-Peter Wachs

Frank-Peter Wachs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of TGF-R signaling for treatment of CNS disorders
    Patent number: 8283334
    Abstract: The present invention relates to the use of oligonucleotides for the preparation of a pharmaceutical composition for the prevention or treatment of a disease, wherein neurogenesis and/or neuroregeneration has a beneficial effect, in particular a disease like Morbus Alzheimer, Morbus Parkinson, Lewy Body Dementia, Amyotrophic Lateral Sclerosis, Spinocerebellar Atrophies, Creutzfeldt Jakob Disease, Frontemporal Dementia, Morbus Pick, AIDS Dementia Complex, Vascular Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Multisystem-Atrophy, Hallervorden Spatz Disease, Huntington's disease, Stroke, Traumatic Brain and spinal cord Injury, Retinitis Pigmentosa, Macular Degeneration, Glaucoma, Cochlea Degeneration, Depression, Schizophrenia, Multiple Sclerosis, and developmental neurodegeneration.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: October 9, 2012
    Inventors: Ulrich Bogdahn, Ludwig Aigner, Frank-Peter Wachs, Beate Winner, Jurgen Winkler
  • Treatment of Central Nervous System Disorders
    Publication number: 20120077741
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells. These methods are useful for reducing at least one symptom of the disorder.
    Type: Application
    Filed: June 14, 2011
    Publication date: March 29, 2012
    Applicant: NeuroNova AB
    Inventors: Kioumars Delfani, Ann Marie Janson, H. Georg Kuhn, Karlheinz Plate, Anne Schanzer, Frank-Peter Wachs, Ming Zhao
  • INHIBITORS OF TGF-R SIGNALING FOR TREATMENT OF CNS DISORDERS
    Publication number: 20110263678
    Abstract: The present invention relates to the use of oligonucleotides for the preparation of a pharmaceutical composition for the prevention or treatment of a disease, wherein neurogenesis and/or neuroregeneration has a beneficial effect, in particular a disease like Morbus Alzheimer, Morbus Parkinson, Lewy Body Dementia,—Amyotrophic Lateral Sclerosis, Spinocerebellar Atrophies, Creutzfeldt Jakob Disease, Frontemporal Dementia, Morbus Pick, AIDS Dementia Complex, Vascular Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Multisystem-Atrophy, Hallervorden Spatz Disease, Huntington's disease, Stroke, Traumatic Brain and spinal cord Injury, Retinitis Pigmentosa, Macular Degeneration, Glaucoma, Cochlea Degeneration, Depression, Schizophrenia, Multiple Sclerosis, and developmental neurodegeneration.
    Type: Application
    Filed: February 15, 2011
    Publication date: October 27, 2011
    Inventors: ULRICH BOGDAHN, Ludwig Aigner, Frank-Peter Wachs, Beate Winner, Jürgen Winkler
  • Inhibitors of TGF-R-signaling for treatment of CNS disorders
    Patent number: 8022045
    Abstract: The present invention relates to the use of oligonucleotides for the preparation of a pharmaceutical composition for the prevention or treatment of a disease, wherein neurogenesis and/or neuroregeneration has a beneficial effect, in particular a disease like Morbus Alzheimer, Morbus Parkinson, Lewy Body Dementia, Amyotrophic Lateral Sclerosis, Spinocerebellar Atrophies, Creutzfeldt Jakob Disease, Frontemporal Dementia, Morbus Pick, AIDS Dementia Complex, Vascular Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Multisystem-Atrophy, Hallervorden Spatz Disease, Huntington's disease, Stroke, Traumatic Brain and spinal cord Injury, Retinitis Pigmentosa, Macular Degeneration, Glaucoma, Cochlea Degeneration, Depression, Schizophrenia, Multiple Sclerosis, and developmental neurodegeneration.
    Type: Grant
    Filed: February 9, 2005
    Date of Patent: September 20, 2011
    Inventors: Ulrich Bogdahn, Ludwig Aigner, Frank-Peter Wachs, Beate Winner, Jürgen Winkler
  • Treatment of Parkinson's disease with PDGF
    Patent number: 7981863
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells. These methods are useful for reducing at least one symptom of the disorder.
    Type: Grant
    Filed: September 18, 2002
    Date of Patent: July 19, 2011
    Assignee: Neuronova AB
    Inventors: Kioumars Delfani, Ann Marie Janson, H. Georg Kuhn, Karlheinz Plate, Anne Schanzer, Frank-Peter Wachs, Ming Zhao
  • Treatment of central nervous system disorders
    Publication number: 20030203844
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells. These methods are useful for reducing at least one symptom of the disorder.
    Type: Application
    Filed: September 18, 2002
    Publication date: October 30, 2003
    Inventors: Kioumars Delfani, Ann Marie Janson, H. Georg Kuhn, Karlheinz Plate, Anne Schanzer, Frank-Peter Wachs, Ming Zhao